is associated with indomethacin treatment failure for patent ductus arteriosus.

Rooney SR, Shelton EL, Aka I, Shaffer CM, Clyman RI, Dagle JM, Ryckman K, Lewis TR, Reese J, Van Driest SL, Kannankeril PJ
Pharmacogenomics. 2019 20 (13): 939-946

PMID: 31486736 · PMCID: PMC6817966 · DOI:10.2217/pgs-2019-0079

MeSH Terms (14)

Cohort Studies Cyclooxygenase Inhibitors Cytochrome P-450 CYP2C9 Ductus Arteriosus, Patent Female Gestational Age Humans Indomethacin Infant Infant, Newborn Infant, Premature Male Treatment Failure Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities:

Links